Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AcroPharma AB (publ)
AB
Active
Org 5593851529
Gasverksgatan 3 A, 222 29
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 4 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
AcroPharma AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
MK
Masoud Khayyami
Chief Executive Officer
Chief Executive Officer
2024
CA
Curt Arne Jesper Ahlkvist
Chief Auditor
Chief Auditor
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
MK
Masoud Khayyami
Board of Directors
Board of Directors
2022
SA
Sebastian Albert Ali Salehi
Chairman
Chairman
2024
CM
Camilla Mary A E Stjärnäng Khayyami
Deputy Board Member
Deputy Board Member
2022
TA
Timothy Adrian Khayyami
Board of Directors
Board of Directors
2024
Former (2)
RA
Rolf Andreas Sjödin
Deputy Board Member
Deputy Board Member
2022 – 2022
LO
Lars Olof Hellman
Board of Directors
Board of Directors
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AcroPharma AB (publ)
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network